Highbridge Capital Management’s Bausch Health BHC Stock Holding History

Highbridge Capital Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-39,940	Closed	-$915K	–	509
2018 Q2	$928K	Buy	39,940 +15,536	+64%	+$321K	0.02%	488
2018 Q1	$389K	Sell	24,404 -12,396	-34%	-$231K	0.01%	768
2017 Q4	$765K	Buy	+36,800	New	+$584K	0.01%	682
2017 Q2	–	Sell	-138,755	Closed	-$1.66M	–	1256
2017 Q1	$1.53M	Buy	138,755 +127,972	+1,187%	+$1.76M	0.02%	499
2016 Q4	$157K	Sell	10,783 -72,417	-87%	-$1.33M	﹤0.01%	1165
2016 Q3	$2.04M	Buy	+83,200	New	+$2.15M	0.03%	429
2016 Q2	–	Sell	-8,932	Closed	-$234K	–	1406
2016 Q1	$234K	Buy	+8,932	New	+$661K	﹤0.01%	1272
2015 Q4	–	Sell	-1,500	Closed	-$268K	–	1504
2015 Q3	$268K	Buy	+1,500	New	+$350K	﹤0.01%	1274
2014 Q4	–	Sell	-138,963	Closed	-$18.2M	–	1172
2014 Q3	$18.2M	Sell	138,963 -166,936	-55%	-$19.9M	0.24%	124
2014 Q2	$38.6M	Buy	+305,899	New	+$39M	0.47%	58

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Highbridge Capital Management's BHC Position: Q3 2018 in Review

Highbridge Capital Management sold out of Bausch Health (BHC) in Q3 2018, closing a stake of 39,940 shares — an estimated $915K sold.

Highbridge Capital Management first reported a position in BHC in Q2 2014 and held it in 10 quarters. The position peaked at $38.6M in Q2 2014. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

Highbridge Capital Management reported no remaining Bausch Health position as of Q3 2018 after selling out during the quarter.
Highbridge Capital Management sold 39,940 Bausch Health shares in Q3 2018, an estimated $915K.
Highbridge Capital Management first reported a position in Bausch Health in Q2 2014 and held it in 10 quarters.
Highbridge Capital Management's Bausch Health position peaked at $38.6M in Q2 2014.
332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.